Vivian R. Albert
Profile
Vivian R.
Albert joined Human Genome Sciences, Inc. as Director of Molecular Biology in 1999 and was appointed Director of the Antibody Discovery and Development Department in May 2000.
She has been Vice President of Preclinical Research and Development for Human Genome Sciences since May 2000.
She was Director of Discovery Biology for Allelix Neuroscience, Inc. Dr. Albert joined Trophix Pharmaceuticals, Inc. in 1995 as Director of Molecular Biology.
Previously, she was an Assistant Member of the Roche Institute of Molecular Biology.
Dr. Albert received an MS in Biology and a BA in Human Biology from Stanford University and PhD in Neurobiology from Cornell University Medical College.
Former positions of Vivian R. Albert
| Companies | Position | End |
|---|---|---|
Trophix Pharmaceuticals, Inc.
 Trophix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of NPS Allelix Corp., Trophix Pharmaceuticals, Inc. develops pharmaceutical products. The company is based in South Plainfield, NJ. The company was founded by Jeffrey F. McKelvy. Trophix Pharmaceuticals was acquired by Allelix Biopharmaceuticals, Inc. on July 30, 1997 for $27 million. | Corporate Officer/Principal | - |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | - |
Training of Vivian R. Albert
| Stanford University | Graduate Degree |
| Cornell University | Doctorate Degree |
Experiences
Positions held
Linked companies
| Private companies | 2 |
|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Trophix Pharmaceuticals, Inc.
Trophix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of NPS Allelix Corp., Trophix Pharmaceuticals, Inc. develops pharmaceutical products. The company is based in South Plainfield, NJ. The company was founded by Jeffrey F. McKelvy. Trophix Pharmaceuticals was acquired by Allelix Biopharmaceuticals, Inc. on July 30, 1997 for $27 million. | Health Technology |
- Stock Market
- Insiders
- Vivian R. Albert
